Latest News & Features
Americas
The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all. 4 June 2020
Europe
Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled. 3 June 2020
Americas
Gilead Sciences has persuaded the US Patent Trial and Appeal Board to review an antiviral patent owned by the University of Minnesota. 2 June 2020
Americas
The US Food and Drug Administration has warned a US Court of Appeals for the DC Circuit decision awarding market exclusivity to Eagle Pharmaceuticals for a cancer drug will have “grave” consequences for patient access. 29 May 2020
Africa
The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative. 29 May 2020
Americas
The PrEP4All campaign has argued that the US government should own joint patent rights for remdesivir, the Gilead Sciences antiviral which is the only drug approved anywhere for treating COVID-19. 28 May 2020
Americas
Merck Sharp & Dohme is pushing forward with three initiatives aimed at combating the COVID-19 pandemic, including the acquisition of vaccine company Themis Bioscience. 28 May 2020
Big Pharma
A new NGO report has sharply criticised the EU-funded Innovative Medicines Initiative as favouring Big Pharma over small businesses, particularly when it comes to IP. 28 May 2020
Americas
Protein engineering company Codexis has accused competitor Codex DNA of trademark infringement through the use of a “virtually identical” mark. 27 May 2020
Americas
London-based Hikma Pharmaceuticals has won approval to launch the first generic version of Vascepa, after having key Amarin patents for the heart drug invalidated. 26 May 2020